Search Close Search
Search Close Search

Conducting collaborative, cutting-edge research
to unravel molecular, cellular and genetic mechanisms of disease and translate our discoveries into innovative therapeutic strategies

 Research.png

Research

Explore how our bold discoveries are redefining our understanding of how diseases start and can be treated.  

 Education.png

Education

Find out how MCCB equips students and early-career researchers with the skills and knowledge to drive scientific discovery.  

 Support Us.png

Support

Learn more about how you can support MCCB’s fundraising initiatives to advance research at UMass Chan.

MCCB Recognitions & Achievements

Grants, Honors & Awards

Getting Results…
  • Headshot of Boris Dimitrov with overlaid text reading “Boris Dimitrov, MD-PhD Student” and “National Cancer Institute F30 Fellowship.”

    MD-PhD Student Receives NCI Fellowship to Study Ferroptosis Resistance in Metastasis

    Boris Dimitrov is investigating how a small population of triple-negative breast cancer cells evades iron-dependent cell death to initiate metastasis.

    Read more

Recent Publications

  • Lero et al. Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer. J Biol Chem, 2026. Article | Shaw Lab
  • Velentzas et al. The pyruvate transporter hermes resultes autophagy and health by modulting ROS production. Cell Rep, 2026. Article | Baehrecke Lab
  • Parikh et al. Multiplexed cytokine and antigen mRNA administration generates durable anti-tumor immunity against pancreatic cancer. Nat Commun, 2026. Article | Ruscetti Lab
  • Wang et al. Cholesterol transfer proteins promote Atg-independent ER clearance by lysosomes. Cell Rep, 2026. Article | Baehrecke Lab
  • Chao and Fazzio. R-loops shape the H2A.Z landscape and promote balanced lineage allocation during differentiation. Genome Res, 2026. Article | Fazzio Lab

More Publications...

Highlights from UMass Chan News

Getting Results…
  • mRNA immunotherapy developed by UMass Chan scientists eliminates pancreatic tumors in mice

    mRNA immunotherapy developed by UMass Chan scientists eliminates pancreatic tumors in mice

    Novel mRNA treatment developed at UMass Chan Medical School eliminates pancreatic cancer tumors in 50 percent of treated mice.

    Read more

Upcoming Events

Page Menu